A case report of verapamil toxicity leading to haemodynamic compromise in obstructive hypertrophic cardiomyopathy
2024

Verapamil Toxicity in Hypertrophic Cardiomyopathy

publication Evidence: low

Author Information

Author(s): Gau Jonathan W, Rader Florian, Mody Behram, Lee Andy Y

Primary Institution: University of California, Irvine

Hypothesis

Can verapamil toxicity lead to hemodynamic compromise in patients with obstructive hypertrophic cardiomyopathy?

Conclusion

Verapamil toxicity can cause significant hemodynamic issues in patients with obstructive hypertrophic cardiomyopathy.

Supporting Evidence

  • The patient experienced cardiogenic shock attributed to verapamil toxicity.
  • His ejection fraction improved from 35% to 75% after adjusting medications.
  • Verapamil's negative inotropic effects were highlighted as a concern in this case.

Takeaway

This study shows that taking too much verapamil can make it hard for the heart to pump blood in people with a specific heart condition.

Methodology

Case report detailing a patient's experience with verapamil toxicity and its effects on heart function.

Limitations

The findings are based on a single case report, limiting generalizability.

Participant Demographics

A 34-year-old man with a history of obstructive hypertrophic cardiomyopathy.

Digital Object Identifier (DOI)

10.1093/ehjcr/ytae596

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication